EKR THERAPEUTICS
EKR Therapeutics, Inc., a specialty pharmaceutical company, focuses on acquiring, developing, and commercializing prescription products and oncology supportive care. It focuses on various areas, including oral mucositis, stomatitis, dry mouth/xerostomia, nutritional issues, cachexia, skin reactions, bone marrow depression, bone complications, acute and chronic pain, nausea, vomiting, and diarrhea. The company was founded in 2005 and is based in Bedminster, New Jersey.
EKR THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2006-02-01
Address:
Bedminster, New Jersey, United States
Country:
United States
Website Url:
http://www.ekrtx.com
Total Employee:
51+
Status:
Active
Contact:
9786831799
Email Addresses:
[email protected]
Total Funding:
163 M USD
Technology used in webpage:
Nginx AliDNS Dingfeng Xinhui
Similar Organizations
Kastle Therapeutics
Kastle Therapeutics is committed to developing innovative products that help underserved patients with unmet medical needs.
Tivorsan Pharmaceuticals
Tivorsan Pharmaceuticals is a protein therapeutics company that focuses on treating neuromuscular disorders.
Current Advisors List
Current Employees Featured
Founder
Investors List
NewSpring
NewSpring investment in Series D - EKR Therapeutics
GE Healthcare
GE Healthcare investment in Debt Financing - EKR Therapeutics
MPM Capital
MPM Capital investment in Series D - EKR Therapeutics
Quaker BioVentures
Quaker BioVentures investment in Series D - EKR Therapeutics
LLR Partners
LLR Partners investment in Series D - EKR Therapeutics
Garden State Life Sciences Venture
Garden State Life Sciences Venture investment in Series D - EKR Therapeutics
ESP Equity Partners
ESP Equity Partners investment in Series D - EKR Therapeutics
Garden State Life Sciences Venture
Garden State Life Sciences Venture investment in Series C - EKR Therapeutics
Merrill Lynch
Merrill Lynch investment in Series C - EKR Therapeutics
NewSpring
NewSpring investment in Series C - EKR Therapeutics
